332 related articles for article (PubMed ID: 20362711)
21. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
[TBL] [Abstract][Full Text] [Related]
22. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
[TBL] [Abstract][Full Text] [Related]
23. ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
Capodanno D; Prati F; Pawlowsky T; Ramazzotti V; Albertucci J; La Manna A; Robert G; Tamburino C
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):130-6. PubMed ID: 19829141
[TBL] [Abstract][Full Text] [Related]
24. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study.
Prati F; Di Vito L; Ramazzotti V; Imola F; Pawlowski T; Materia L; Tavazzi L; Biondi-Zoccai G; Albertucci M
J Cardiovasc Med (Hagerstown); 2013 May; 14(5):364-71. PubMed ID: 22929568
[TBL] [Abstract][Full Text] [Related]
26. Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial.
Desch S; Wöhrle J; Hambrecht R; Rittger H; Birkemeyer R; Lauer B; Neuhaus P; Brosteanu O; Sick P; Pauschinger M; Kerber S; Kleinertz K; de Waha S; Eitel I; Schuler G; Thiele H
J Am Coll Cardiol; 2013 Sep; 62(13):1214-5. PubMed ID: 23850911
[No Abstract] [Full Text] [Related]
27. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction.
Piccolo R; Galasso G; Eitel I; Dominguez-Rodriguez A; Iversen AZ; Gu YL; Abreu-Gonzalez P; de Smet BJ; Esposito G; Windecker S; Thiele H; Piscione F
Am J Cardiol; 2016 Dec; 118(12):1798-1804. PubMed ID: 27756477
[TBL] [Abstract][Full Text] [Related]
28. Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Bosa-Ojeda F; Samimi-Fard S; Marrero-Rodriguez F; Kaski JC
Atherosclerosis; 2009 Oct; 206(2):523-7. PubMed ID: 19380134
[TBL] [Abstract][Full Text] [Related]
29. Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration.
Gu YL; Fokkema ML; Kampinga MA; de Smet BJ; Tan ES; van den Heuvel AF; Zijlstra F
Trials; 2009 Sep; 10():90. PubMed ID: 19785725
[TBL] [Abstract][Full Text] [Related]
30. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial.
Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA
Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177
[TBL] [Abstract][Full Text] [Related]
31. 1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
Piccolo R; Eitel I; Galasso G; Dominguez-Rodriguez A; Iversen AZ; Abreu-Gonzalez P; Windecker S; Thiele H; Piscione F
J Am Coll Cardiol; 2016 Aug; 68(7):727-38. PubMed ID: 27515333
[TBL] [Abstract][Full Text] [Related]
32. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
[TBL] [Abstract][Full Text] [Related]
33. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
[TBL] [Abstract][Full Text] [Related]
34. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
[TBL] [Abstract][Full Text] [Related]
35. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
[TBL] [Abstract][Full Text] [Related]
36. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry.
Dudek D; Siudak Z; Janzon M; Birkemeyer R; Aldama-Lopez G; Lettieri C; Janus B; Wisniewski A; Berti S; Olivari Z; Rakowski T; Partyka L; Goedicke J; Zmudka K;
Am Heart J; 2008 Dec; 156(6):1147-54. PubMed ID: 19033011
[TBL] [Abstract][Full Text] [Related]
37. Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.
Ohlmann P; Reydel P; Jacquemin L; Adnet F; Wolf O; Bartier JC; Weiss A; Lapostolle F; Gaultier C; Salengro E; Benamer H; Guyon P; Chevalier B; Catan S; Ecollan P; Chouihed T; Angioi M; Zupan M; Bronner F; Bareiss P; Steg G; Montalescot G; Monassier JP; Morel O
Circ Cardiovasc Interv; 2012 Feb; 5(1):69-76, S1. PubMed ID: 22319064
[TBL] [Abstract][Full Text] [Related]
38. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.
Brener SJ; Witzenbichler B; Maehara A; Dizon J; Fahy M; El-Omar M; Dambrink JH; Genereux P; Mehran R; Oldroyd K; Parise H; Gibson CM; Stone GW
Am Heart J; 2013 Jul; 166(1):64-70. PubMed ID: 23816023
[TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
[TBL] [Abstract][Full Text] [Related]
40. Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty.
Tarantini G; Ramondo A; Corbetti F; Perazzolo Marra M; Cacciavillani L; Napodano M; Bilato C; Razzolini R; Iliceto S
Cardiology; 2008; 110(2):129-34. PubMed ID: 17971662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]